|
AUTS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.770000E-04 |
| Normal-vs-Stage3 |
3.87349996522346E-09 |
| Normal-vs-Stage4 |
2.03139999999102E-06 |
| Stage1-vs-Stage2 |
1.992230E-01 |
| Stage1-vs-Stage3 |
6.263800E-01 |
| Stage1-vs-Stage4 |
3.168000E-01 |
| Stage2-vs-Stage3 |
4.289400E-01 |
| Stage2-vs-Stage4 |
8.415800E-02 |
| Stage3-vs-Stage4 |
2.046400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.103180E-03 |
| Normal-vs-Asian |
2.06319999999094E-05 |
| Caucasian-vs-AfricanAmerican |
2.122000E-01 |
| Caucasian-vs-Asian |
1.962220E-01 |
| AfricanAmerican-vs-Asian |
7.774200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-15 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
3.983400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6304735339645E-12 |
| Normal-vs-Age(41-60Yrs) |
8.54871728961371E-15 |
| Normal-vs-Age(61-80Yrs) |
2.10670003664148E-09 |
| Normal-vs-Age(81-100Yrs) |
3.000000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.701200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.139200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.735000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.810800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.203800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.380600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.884400E-03 |
| Classical-VS-Follicular |
1.20550000004549E-06 |
| Classical-VS-Other |
7.471200E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
3.080800E-01 |
| Tall-VS-Other |
2.648800E-01 |
| Tall-VS-Normal |
4.23210000000118E-05 |
| Follicular-VS-Other |
3.930100E-02 |
| Follicular-VS-Normal |
1.005240E-04 |
| Other-VS-Normal |
3.202300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62891922173003E-12 |
| Normal-vs-N1 |
1.63900999999855E-05 |
| N0-vs-N1 |
2.373200E-01 |
|
|
